Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
JournalBritish Journal of Dermatology
Volume188
Issue number6
Pages (from-to)793-794
Number of pages2
ISSN0007-0963
DOIs
Publication statusPublished - 2023

ID: 386607021